Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
GlaxoSmithKline to buy Chinese company for $70M
Bizjournals.com
Tue, 12/7/10 - 11:40 am
China
GSK
M&A
Nanjing MeiRui
Glaxo Finally Gives Up on Fountain of Youth Pill
Seeking Alpha
Sun, 12/5/10 - 11:55 am
GSK
SRT501
Sirtris
Valeant, GSK Prepare for Approval of Anti-Epileptic Drug Despite Latest Delay
Seeking Alpha
Sun, 12/5/10 - 11:53 am
Valeant Pharmaceuticals
GSK
epilepsy
Potiga
Advisory Votes Against Expanding Use of GSK’s, Merck’s Prostate Drugs: Biotech's Latest Tribulations
Seeking Alpha
Sun, 12/5/10 - 11:52 am
GSK
Merck
Avodart
enlarged prostate
prostate cancer
Proscar
Orexigen
obesity
Contrave
Novartis
JNJ
Merck KGaA
Setback for Valeant Epilepsy Drug
Yahoo/Zacks
Sat, 12/4/10 - 12:18 pm
Valeant Pharmaceuticals
epilepsy
ezogabine
GSK
Which Drugmakers Will Take You Higher?
Minyanville
Sat, 12/4/10 - 12:13 pm
Novartis
GSK
JNJ
Pfizer
AstraZeneca
Human Genome Sciences and GlaxoSmithKline Announce FDA Extension of BENLYSTA® PDUFA Target Date to March 10, 2011
Yahoo/BusinessWire
Sat, 12/4/10 - 11:58 am
Human Genome Sciences
GSK
Benlysta
PDUFA
GlaxoSmithKline Grows Theravance Stake: Investing in the Pipeline
Seeking Alpha
Sat, 12/4/10 - 11:57 am
GSK
Theravance
Ex-Glaxo lawyer pleads not guilty to obstruction
Reuters
Thu, 12/2/10 - 12:15 pm
GSK
antidepressants
Glaxo Nears Deal to Buy Chinese Drug Firm
WSJ Online
Thu, 12/2/10 - 10:02 am
Nanjing MeiRui
M&A
GSK
China
Glaxo Fails to Win Panel’s Vote for Wider Avodart Use
Bloomberg
Wed, 12/1/10 - 09:02 pm
GSK
Avodart
advisory panels
prostate cancer
For GSK, It’s Last Call For a Drug Based on Resveratrol
WSJ Online
Wed, 12/1/10 - 05:54 pm
GSK
Resveratrol
Docs Like Reps From Which Company The Most?
Pharmalot
Wed, 12/1/10 - 11:37 am
drug reps
physicians
GSK
FDA disputes prostate drugs' risk-cutting power
Fierce Pharma
Tue, 11/30/10 - 10:59 am
FDA
GSK
prostate cancer
Avodart
Merck
Proscar
Drug Maker Wrote Book Under 2 Doctors’ Names, Documents Say
NY Times, NY
Tue, 11/30/10 - 07:56 am
GSK
physician payments
Ghostwriting
Drug groups face new generics threat
FT.com
Mon, 11/29/10 - 02:50 pm
generics
Roche
Merck
JNJ
Abbott Laboratories
GSK
AstraZeneca
Teva Pharmaceuticals
Hospira
Novartis
Glaxo’s Avodart Faces FDA Questions on Prostate Cancer Benefits
Bloomberg
Mon, 11/29/10 - 09:55 am
GSK
Avodart
prostate cancer
Let’s Have a Healthy Dialogue in the Drug Sector
WSJ Online
Mon, 11/29/10 - 09:07 am
Bayer
GSK
Novartis
Eli Lilly
JNJ
social media
AstraZeneca
twitter
Glaxo to increase Theravance shareholding
Yahoo/AP
Mon, 11/29/10 - 09:05 am
Theravance
GSK
Actelion Takeover: Constant Speculation, Doubts Linger
Seeking Alpha
Mon, 11/29/10 - 09:04 am
M&A
Abbott Laboratories
Actelion
GSK
JNJ
Roche
Amgen
Bristol-Myers Squibb
Pages
« first
‹ previous
…
131
132
133
134
135
136
137
138
139
…
next ›
last »